No Detail Found!

Serum Irisin Levels and Cardiovascular Risk in Obese Patients before and after Bariatric Surgery

Author(s)
Rehab A. Karam Department of Biochemistry, College of Medicine, Taif University Taif, Saudi Arabia
Haidy E. Zidan Department of Biochemistry, Faculty of Medicine, Zagazig University, Zagazig, Egypt
Nana Abdelrahman Department of Microbiology, Faculty of Medicine, Zagazig University, Zagazig, Egypt; Department of Microbiology, College of Medicine, King Abdul Aziz University, Jeddah, Saudi Arabia
Amal F. Gharib Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia
Owaid M. Almalki Department of Surgery, College of Medicine, Taif University, Taif, Saudi Arabia
Tamer. M. Abdelrahman Department of Surgery, College of Medicine, Taif University, Taif, Saudi Arabia
Abstract
Objectives: Irisin has emerged as a potential cardiovascular biomarker with protective effects. This study aimed to evaluate serum irisin levels and FNDC5 gene expression in obese individuals undergoing bariatric surgery and to assess irisin's role as a cardiovascular biomarker in obesity and post-surgery. Method: Forty severely obese participants and 40 healthy, normal-weight controls were evaluated at baseline, 6 months and 12 months after surgery. Serum irisin was measured using ELISA and FNDC5 gene expression was assessed via Real-Time PCR. Various biochemical, anthropometric and clinical parameters were also measured. Results: Serum irisin levels decreased significantly from 10.45±2.49 ng/mL at baseline to 7.66±1.49 ng/mL at 12 months post-surgery (p = 0.000). FNDC5 gene expression also significantly declined (p = 0.000). Irisin levels were positively correlated with BMI and FNDC5 expression and inversely correlated with cholesterol, LDL, triglycerides, CRP, MDA and hs-Tn. Higher irisin levels were associated with lower cholesterol, LDL, CRP and MDA levels. At 12 months, irisin was negatively correlated with cholesterol, ApoB/ApoA ratio and hs-Tn. Conclusion: Irisin may serve as a cardiovascular biomarker in obese individuals both before and after bariatric surgery. Elevated irisin levels are associated with obesity but decrease following surgery, correlating with inflammatory markers and cardiovascular risk factors. These results suggest that higher irisin levels could be linked to a lower cardiovascular risk in obese patients.
Publication Details
Page(s) 157-164
Published Journal: Journal of Pioneering Medical Sciences, Volume: 13, Issue: 7, Year: 2024

Request the full text from PASTIC

Keywords
Irisin, Real-time PCR, FNDC5, BMI
References
C. ,Bárbara G.H.,Citores and J. ArancetaBartrina M.G. .2022 .Prevalence of obesity and associated cardiovascular risk factors in the spanish population: The enpe study. Rev. Española Cardiol, 75 : 232-241.
El-Bcheraoui C.,Afshin A.,Charara R.,Khalil I.,Moradi-Lakeh M. .2018 .Burden of obesity in the eastern mediterranean region: findings from the global burden of disease 2015 study. Int. J Public Health.,, 63 : 165-176.
H. ,Ansari-Moghaddam A.,Kargar S.,Jabbari N. .2022 .Prevalence of obesity and overweight among adults in the middle east countries from 2000 to 2020: A systematic review and metaanalysis. J. Obesity, 10 : .
Lopez-Jimenez .,F. .,Almahmeed W.,Bays H.,Cuevas A.,Angelantonio E.D. .2022 .Obesity and cardiovascular disease: Mechanistic insights and management strategies. a joint position paper by the world heart federation and world obesity federation. Eur. J. Preventive Cardiol, 29 : 2218-2237.
J. Wu P.,Jedrychowski M.P.,Korde A.,Ye L. .2012 .A pgc1-"-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481 : 463-468.
Panati .,K. .,Suneetha Y.,Narala V.R. .2016 .Irisin/FNDC5-An updated review. Eur. Rev. Med, 20 : 689-697.
Zhang .,Hu C.,H.M. Wu Z.G.,Ma Q.Z.,Tang Q.Z. .2020 .Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: A promising biomarker and therapeutic target. Acta Pharmacol. Sinica, 42 : 1390-1400.
Xiong X.Q.,Ren X.S.,Zhao M.X.,Shi C.X. .2016 .FNDC5 alleviates hepatosteatosis by restoring AMPK/mTOR-mediated autophagy, fatty acid oxidation and lipogenesis in mice. Diabetes, 65 : 3262-3275.
Zhang .,Hu C.,Kong C.Y.,Song and H.M. Wu P. .2019 .Cell Death Differ. , 27 : 540-555.
C. ,Zhang X.,Teng T.,Yuan Y. .2022 .Fibronectin type III domain containing 5 improves aging related cardiac dysfunction in mice. Aging Cell, 21 : .
J.D.S. ,Camacho F.A.,Cavararo C.D.S.,Baião P.F.,Medeiros R.F.,Barroso S.G.,A.C.D. Matos S.G. .2023 .Irisin and cardiometabolic disorders in obesity: A systematic review. Int. J. Inflam., 10 : .
W. ,Shaker Y.,Hamimy W.I.,Afify M. .2018 .Assessment of serum vitamin D and irisin levels in obese patients. Clin. Lab., 64 : 180416.
Marandi S.M.,Ghaedi K.,Safaeinejad Z.,Esfarjani F.,Nasr-Esfahani M.H.,Nutr M.H. .2018 .A comparative study on the effects of high-fat diet and endurance training on the PGC-1"-FNDC5/Irisin pathway in obese and nonobese male C57BL/6 mice. , 43 : 651-662.
F. ,Benomar K.,Espiard S.,Vahe and K.L. Mapihan C. .2019 .Irisin levels in LMNA-associated partial lipodystrophies. Diabetes Metab, 45 : 67-75.
B.M. ,Pena-Bello L.,Juiz-Valiña P.,VidalBretal B.,Cordido F.,Sangiao-Alvarellos S. .2016 .FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle. Sci. Rep, 6 : .
D. ,Roca-Rivada A.,I. Baamonde A.,Baltar J.,A.I. Castro J. .2017 .Lack of adipocyte-Fndc5/Irisin expression and secretion reduces thermogenesis and enhances adipogenesis. Sci. Rep, 7 : .
S. ,Li F.,Li H.,Huang Y.,Liu Y.,Chen Y. .2016 .Effects and Molecular Mechanism of GST-Irisin on Lipolysis and Autocrine Function in 3T3-L1 Adipocytes. Plos One, 0147480 : .
J.M. ,Ortega F.,Serrano M.,Guerra E.,Pardo G. .2013 .Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab., 98 : E769-E778.
B. ,Shi X.,Zhang H.,Pan L.,Ma Z. .2014 .Association of serum irisin with metabolic syndrome in obese Chinese adults. Plos One, 0094235 : .
W.K.C. ,Yu A.P.,Lai and P.M. Siu C.W.K. .2018 .Association of markers of proinflammatory phenotype and beige adipogenesis with metabolic syndrome in Chinese centrally obese adults. J. Diabetes Res., 10 : .
Panagiotou G.,Mougios V.,Brinkoetter M.,Vamvini M.T.,Schneider B.E.,Mantzoros C.S. .2012 .circulating concentrations in response to weight loss and exercise. Metabolism, 61 : 1725-1738.
J. ,Rosa A.,Azcona-Granada N.,Peña E.,Ricart-Jané D. .2023 .Irisin as a Novel Biomarker of Subclinical Atherosclerosis in Severe Obesity. Int. J. Mol. Sci., 24 : .
M.H. ,Alotaibi F.,Dsouza C. .2022 .Changes in the expression of meteorin-like (METRNL), irisin (FNDC5) and uncoupling proteins (UCPs) after bariatric surgery. Obesity, 30 : 1629-1638.
G. ,Mu L.,Na B.,Mukamal K.J.,Mantzoros C.S. .2014 .Circulating irisin, omentin-1 and lipoprotein subparticles in adults at higher cardiovascular risk. Metabolism, 63 : 1265-1271.
Ancira M. .2015 .Irisin levels before and after physical activity among school-age children with different BMI: a direct relation with leptin. Obesity, 23 : 729-732.
Kim H.J.,Kang J.H.,Park S.I.,Park K.H.,Lee H.J. .2017 .Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Metabolism, 73 : 100-108.
Ebrahimzadeh F.,Abbasnezhad A.,Khosroshahi M.Z.,Choghakhori R.,Asbaghi O. .2019 .Association between circulating irisin and c-reactive protein levels: A systematic review and metaanalysis. Endocrinol. Metab., 3 : .
A. ,Rouskas K.,Pattou F.,Staels B. .2015 .Bariatric surgery, lipoprotein metabolism and cardiovascular risk. Curr. Opin. Lipidology, 26 : 317-324.
J.F. ,Larson M.G.,Vasan R.S.,Wilson P.W.F.,I. Lipinska P.W.F. .2003 .Obesity and systemic oxidative stress. Arteriosclerosis Thrombosis Vasc. Biol, 23 : 434-439.
Grubman S.,Allen S.,Ye Z.,Park D.Y. .2024 .Clinical interpretation of serum troponin in the era of high-sensitivity testing. Diagnostics, 14 : .
C.E. ,Matsushita K.,Shay C.M.,Folsom A.R.,Ballantyne C.M.,Brancati F.L. .2016 .High-sensitivity troponin T as an independent predictor of heart failure in chronic kidney disease: The ARIC study. Circulation, 133 : 145-151.
A. ,Patel K.V.,Gao A.,Ayers C.,Ballantyne C.M.,Drazner M.H. .2019 .Incorporation of high-sensitivity troponin T into cardiovascular risk assessment algorithms: Insights from the Dallas Heart Study. Circulation, 140 : 541-551.
Y. ,Li R.,Meng Y.,Li S.,Donelan W. .2014 .Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes, 63 : 514-525.
J.D. Linderman P.,Smith S.,Brychta R.J.,Wang J. .2014 .Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab, 19 : 302-309.
Xie C.,Wang H.,Foss R.M.,Clare M. .2016 .Irisin exerts dual effects on browning and adipogenesis of human white adipocytes. Am. J. Physiol. Endocrinol. Metab., 311 : E530-E541.
H. ,Shen J.,Wu T.,Kuang J.,Liu Q. .2019 .Irisin is controlled by farnesoid X receptor and regulates cholesterol homeostasis. Front. Pharmacol., 00548 : .
L. ,Uzel K.E.,Tanriverdi O.,Turkmen S. .2020 .Serum irisin: Pathogenesis and clinical research in cardiovascular diseases. Cardiovasc. Innovations Appl., 4 : 195-200.
J. ,Cuello E.,Ricart-Jané D.,Miñarro A.,Baena-Fustegueras J.A.,Peinado-Onsurbe J.,Pardina E. .2020 .Effect of bariatric surgery on inflammation and endothelial dysfunction as processes underlying subclinical atherosclerosis in morbid obesity. Surg, 16 : 1961-1970.
M.L. .2006 .Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr. Med. Res. Opin., 22 : 2181-2190.
K. ,Chin-Dusting J. .2007 .Therapeutic targeting of pselectin in atherosclerosis. Inflamm. Allergy Drug Targets, 6 : 69-74.
Liu M.,Mei W.,Xiang L.,Dong J. .2015 .Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis, 243 : 438-448.
Mu Q.,Zhou Z.,Song H.,Zhang Y. .2016 .Protective effect of irisin on atherosclerosis via suppressing oxidized low density lipoprotein induced vascular inflammation and endothelial dysfunction. Plos One, 01 : .
El-Sherbeiny and M.Z. Boraie S.M.S. .2018 .Correlation between the blood level of irisin and the severity of acute myocardial infarction in exercise-trained rats. J. Basic Clin. Physiol. Pharmacol., 30 : 59-71.
D. ,Melekoglu A.,Calik M.,Kosem A. .2023 .Association between serum irisin levels and ST-segment elevation myocardial infarction. Int. J. Gen. Med, 16 : 1355-1362.
R. ,Zhang Q.,Peng N.,Xu S.,Zhang M. .2021 .Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population. Bmc Cardiovasc. Disord., 21 : .
0

Citations

0

Downloads

20

Views